Mount Sinai launches Center for Genomic AI and Microbiome Medicine to advance precision medicine
The Icahn School of Medicine at Mount Sinai has launched the Center for Genomic AI and Microbiome Medicine, a research center that will bring together human genetics and microbiome research…
TOFA: a weight loss, diabetes treatment, burn fat and keeping muscle
Over the past five years, medications called GLP-1s have revolutionized the treatment of metabolic disorders like obesity, diabetes and fatty liver diseases. Sold under the brand names Ozempic, Wegovy, Mounjaro…
NICE recommends new treatment option for people with blood and lymphatic cancers
Hundreds of people are set to benefit as NICE recommends acalabrutinib for newly diagnosed mantle cell lymphoma and chronic lymphocytic leukaemia Mantle cell lymphoma MCL is a rare and aggressive…
A new DNA-based strategy for tackling gum disease
Periodontitis is one of the most common chronic inflammatory diseases worldwide and a leading cause of tooth loss in adults. Triggered by bacterial plaque that accumulates beneath the gums, the…
FDA Approves First Gene Therapy for Young Children with Sickle Cell Disease
The U.S. Food and Drug Administration today issued a supplemental approval for Casgevy* (exagamglogene autotemcel) for patients aged 2 years and older with either sickle cell disease (SCD) with recurrent…
More than 1.15 million fertility treatment cycles reported across Europe and the impact of frozen embryo transfer continues to grow #ESHRE2026
More than 1.15 million assisted reproductive technology (ART) treatment cycles were reported across Europe in 2023, according to preliminary data presented by the European IVF Monitoring (EIM) Consortium at the…
New evidence on therapies that protect the heart from anticancer drugs
The cardioprotective effects of heart failure treatments in patients with cancer were demonstrated today in a presentation at ESC Cardio-Oncology 2026,1 the annual conference of the European Society of Cardiology’s…
Stem Cell Transplantation More Cost-Effective than Gene Therapy for Sickle Cell Disease
Stem cell transplantation is the most cost-effective option for long-term care of sickle cell disease in adults when compared with gene therapy and standard of care treatment, according to new…
Pfizer’ s BRAFTOVI* Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer #ASCO26
Pfizer announced detailed progression-free and overall survival results from Cohort 3, a randomized cohort of the Phase 3 BREAKWATER trial, evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (ERBITUX®) and FOLFIRI…
Experts call for women’s heart centres to tackle inequality in diagnosis & care
Women are more likely to face delays in diagnosis of cardiovascular disease and, as a result, they are more likely to die or develop more serious illness. To address this…